<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2016-2-3-3-10</article-id><article-id pub-id-type="publisher-id">766</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>MODERN REVIEW: HELICOBACTER PYLORI AND RISK OF CORONARY HEART DISEASE</article-title><trans-title-group xml:lang="en"><trans-title>MODERN REVIEW: HELICOBACTER PYLORI AND RISK OF CORONARY HEART DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Gusejnli</surname><given-names>El'maddin G.</given-names></name><name xml:lang="en"><surname>Gusejnli</surname><given-names>El'maddin G.</given-names></name></name-alternatives><email>elmaddin93@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Efremova</surname><given-names>Olga A.</given-names></name><name xml:lang="en"><surname>Efremova</surname><given-names>Olga A.</given-names></name></name-alternatives><email>efremova@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kamyshnikova</surname><given-names>Lyudmila A.</given-names></name><name xml:lang="en"><surname>Kamyshnikova</surname><given-names>Lyudmila A.</given-names></name></name-alternatives><email>kamyshnikova@bsu.edu.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2016</year></pub-date><volume>2</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2016/3/Медицина_и_фармация_3-4-11.pdf" /><abstract xml:lang="ru"><p>The article analyzes the data, foreign and the Russian literature about the relationship of Helicobacter pylori infection and the risk of cardiovascular disease. Are analyzed variations of pathogenetic mechanisms of correlation Helicobacter pylori and coronary heart disease risk. There is increasing evidence that certain microbial agents may have an etiopathogenic role in the development of atherothrombosis. Helicobacter pylori, a bacterium that causes peptic ulcer disease, has been suggested as one of the microbes involved in the development of atherothrombosis. This hypothesis is based on the following observations: a higher prevalence of Helicobacter pylori infection in patients with coronary artery disease, myocardial infarction, or cerebrovascular disease; the coincidence of Helicobacter pylori infection and cardiovascular risk factors, such as serum cholesterol and triglyceride concentrations and plasma fibrinogen; Helicobacter pylori seropositivity correlates with acute-phase proteins associated with higher risk of coronary disease, such as C-reactive protein, and controversial PCR studies indicating the presence of Helicobacter pylori in atheromas. Analysis of the scientific evidence suggests that Helicobacter pylori infection could indirectly contribute to the development and severity of atherothrombosis and cardiovascular disease. According to our opinion, are required a very large randomized studies to prove the truth of the presence of a possible connection between H. pylori and cardiovascular disease</p></abstract><trans-abstract xml:lang="en"><p>The article analyzes the data, foreign and the Russian literature about the relationship of Helicobacter pylori infection and the risk of cardiovascular disease. Are analyzed variations of pathogenetic mechanisms of correlation Helicobacter pylori and coronary heart disease risk. There is increasing evidence that certain microbial agents may have an etiopathogenic role in the development of atherothrombosis. Helicobacter pylori, a bacterium that causes peptic ulcer disease, has been suggested as one of the microbes involved in the development of atherothrombosis. This hypothesis is based on the following observations: a higher prevalence of Helicobacter pylori infection in patients with coronary artery disease, myocardial infarction, or cerebrovascular disease; the coincidence of Helicobacter pylori infection and cardiovascular risk factors, such as serum cholesterol and triglyceride concentrations and plasma fibrinogen; Helicobacter pylori seropositivity correlates with acute-phase proteins associated with higher risk of coronary disease, such as C-reactive protein, and controversial PCR studies indicating the presence of Helicobacter pylori in atheromas. Analysis of the scientific evidence suggests that Helicobacter pylori infection could indirectly contribute to the development and severity of atherothrombosis and cardiovascular disease. According to our opinion, are required a very large randomized studies to prove the truth of the presence of a possible connection between H. pylori and cardiovascular disease</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Helicobacter pylori</kwd><kwd>cardiovascular risk factor</kwd><kwd>coronary heart disease</kwd><kwd>аtherosclerosis</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Helicobacter pylori</kwd><kwd>cardiovascular risk factor</kwd><kwd>coronary heart disease</kwd><kwd>аtherosclerosis</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Alekseeva O.P., Pikulev D.V., Dolbin I.V. Coronary heart disease and gastroesophageal reflux disease: mutual burdening syndrome (Clinical illustration). Clinical prospects of gastroenterology, hepatology. 2012. № 3: 31-34</mixed-citation></ref><ref id="B2"><mixed-citation>Arkaykina L.C., Matveeva L.V., Mosina L.M. Out stomach manifestations helikobakterioz // Successes of modern science. 2011. №8: 87-88.</mixed-citation></ref><ref id="B3"><mixed-citation>Belyalov F.I. Treatment of internal diseases in comorbidity. Monograph, Ed. 9th. Irkutsk: RIO IGIUVa, 2013. 296 р.</mixed-citation></ref><ref id="B4"><mixed-citation>Dworkin M.I. Etiopathogenesis relationship of Helicobacter pylori infection with atherosclerosis. Herald KRSU. 2014. Vol 14. № 10: 101-104</mixed-citation></ref><ref id="B5"><mixed-citation>Efremova O.A., Kamyshnikova L.A., Nikitin V.M., Zheleznova E.A., Lipunova E.A., Anokhin D.A. Diagnosis of coronary heart disease intellectual system &amp;quot;ARM cardiologist. Journal&amp;quot; People &amp;amp; Health&amp;quot;. 2014. 1: 69-75.</mixed-citation></ref><ref id="B6"><mixed-citation>Zvenigorodskaya L.A., Bondarenko E.U, Morozov I.A., Chikunov B.Z. Peptic ulcer disease in the elderly: clinical features and the value of H. pylori. Clinical Gerontology. 2007. №1: 9-14.</mixed-citation></ref><ref id="B7"><mixed-citation>Kamyshnikova L.A., Makaryan B.S. Assessment of Compliance with the Principles of a Healthy lifestyle at a Young Age and Cardiovascular Risk Assessment on the Example of Students of the Institute of Medicine. Research results. Medicine and pharmacy series. 2015. №2: 62-68.</mixed-citation></ref><ref id="B8"><mixed-citation>Simonova Zh.G., Martusevich A.K., Tarlovskaya E.I. Combined cardiovascular and gastroduodenal pathology. Kirov, 2013.132 р.</mixed-citation></ref><ref id="B9"><mixed-citation>Fadeenko G.D. Out stomach effects of Helicobacter pylori infection Healthy Ukrain. 2006. №5: 1-5</mixed-citation></ref><ref id="B10"><mixed-citation>10.&amp;nbsp;&amp;nbsp;&amp;nbsp; Ayada K., Yokota K., Kobayashi K. et al. Chronic infections and atherosclerosis. Clin Rev Allergy Immunol. 2009. 37: 44&amp;mdash;48.</mixed-citation></ref><ref id="B11"><mixed-citation>11.&amp;nbsp;&amp;nbsp;&amp;nbsp; Birnie D., Holme R., McKay I., Hood S., McColl K., Hillis W. Association between antibodies to heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J. 1998. 319: 387-94.</mixed-citation></ref><ref id="B12"><mixed-citation>12.&amp;nbsp;&amp;nbsp;&amp;nbsp; Blasi F., Denti F., Erba M., Cosentini R., Raccanelli R., Rinaldi A., et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996. 34: 2766-2775.</mixed-citation></ref><ref id="B13"><mixed-citation>13.&amp;nbsp;&amp;nbsp;&amp;nbsp; Clarke R., Daly L., Robinson K, et al. Hyperthomocysteinemia: an independent risk factor for vascular disease. N Engl J Me 1991. 324: 1149-1155.</mixed-citation></ref><ref id="B14"><mixed-citation>14.&amp;nbsp;&amp;nbsp;&amp;nbsp; El-Marshad N. еt al. Relation of Cag A-positive Helicobacter Pylori strain and some inflammatory markers in patients with ischemic heart diseases // Egypty immunol. 2009. 16 (1): 39&amp;ndash;46.</mixed-citation></ref><ref id="B15"><mixed-citation>15.&amp;nbsp;&amp;nbsp;&amp;nbsp; Franceschi F., Niccoli G., Ferrante G. et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009. 202: 535-542.</mixed-citation></ref><ref id="B16"><mixed-citation>16.&amp;nbsp;&amp;nbsp;&amp;nbsp; Gonz&amp;aacute;lez-Valencia G., P&amp;eacute;rez-P&amp;eacute;rez G., Washburn R., Blaser M. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter 1996. 1: 28-33.</mixed-citation></ref><ref id="B17"><mixed-citation>17.&amp;nbsp;&amp;nbsp;&amp;nbsp; Kalia N., Jacob S., Brown N., Reed M., Morton D., Bardhan K. Studies on the gastric mucosal microcirculation. Helicobacter pylori water soluble extracts induce platelet agregation in the gastric mucosal microcirculation in vivo. Gut 1997. 41: 748-52.</mixed-citation></ref><ref id="B18"><mixed-citation>18.&amp;nbsp;&amp;nbsp;&amp;nbsp; Khodaii Z. et al. Association of Helicobacter Pylori infection with acute myocardial infarction // Coron Artery Duc. 2011. Jan. 22 (1): 6&amp;ndash;11.</mixed-citation></ref><ref id="B19"><mixed-citation>19.&amp;nbsp;&amp;nbsp;&amp;nbsp; Longo-Mbenza B. Helicobacter pylori and atherosclerosis: can current data be useful for clinical practice? Int J Cardio 2009. 135: 76-77.</mixed-citation></ref><ref id="B20"><mixed-citation>20.&amp;nbsp;&amp;nbsp;&amp;nbsp; Malfertheiner P., Megraud F., O&amp;rsquo;Morain C.A., Atherton J., Axon A.Т.R., Bazzoli F., Gensini G.F., Gisbert J.P., Graham D.Y., Rokkas T., El-Omar E.M., Kuipers E.J., The European Hylicobacter Study Group (EHSG). Management of Helicobacter pylori infection - the Maastricht&amp;mdash;IV/Florence Consensus Report. Gut 2012. 61: 646-664.</mixed-citation></ref><ref id="B21"><mixed-citation>21.&amp;nbsp;&amp;nbsp;&amp;nbsp; May K. Ismael, Mahmood R. Al-Haleem, Rawaa S. Salman Evaluation of Anti-Helicobacter pylori Antibodies in A group of Iraqi Patients with Atherosclerosis and Coronary Artery Disease. Iraqi Journal of Science. 2015. Vol 56, N.1A: 81-88.</mixed-citation></ref><ref id="B22"><mixed-citation>22.&amp;nbsp;&amp;nbsp;&amp;nbsp; Monaco C. et al. Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden // J. Am. Coll. Cardiol. 2005. Vol. 45 (2): 238-243.</mixed-citation></ref><ref id="B23"><mixed-citation>23.&amp;nbsp;&amp;nbsp;&amp;nbsp; Niemel&amp;auml;S., Karttunen T., Korhonen T., L&amp;auml;&amp;auml;r&amp;auml; E., Karttunen R., Ik&amp;auml;heino M., et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996. 75: 573-578.</mixed-citation></ref><ref id="B24"><mixed-citation>24.&amp;nbsp;&amp;nbsp;&amp;nbsp; Oshima T. et. al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects // J.Am. Coll. Card. 2005. Vol. 45: 1219-1222.</mixed-citation></ref><ref id="B25"><mixed-citation>25.&amp;nbsp;&amp;nbsp;&amp;nbsp; Patel P., Carrington D., Strachan D., Leatham E., Goggin P., Northfield T., et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994;343:1634-5.</mixed-citation></ref><ref id="B26"><mixed-citation>26.&amp;nbsp;&amp;nbsp;&amp;nbsp; Pattis I. et al. The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of theCagA effector protein // Microbiology. 2007. Vol. 153: 2896&amp;ndash;2909.</mixed-citation></ref><ref id="B27"><mixed-citation>27.&amp;nbsp;&amp;nbsp;&amp;nbsp; Pellicano R. et al. Helicobacter pylori and coronary heart disease: which directions for future studies? // Crit. Rev. Microbiol. 2003. Vol. 29 (4): 351-359.</mixed-citation></ref><ref id="B28"><mixed-citation>28.&amp;nbsp;&amp;nbsp;&amp;nbsp; Rasmi Y., Raeisi S. Possible role of Helicobacter pylori infection via microvascular dysfunction in cardiac syndrome X // Cardiol. J. 2009. Vol. 16, N 6: 585&amp;ndash;587.</mixed-citation></ref><ref id="B29"><mixed-citation>29.&amp;nbsp;&amp;nbsp;&amp;nbsp; Regnstr&amp;ouml;m J., Jovinge S., Bavenholm P., Ericson C., De Faire U., Hamsten A., et al. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J Int Med 1998. 243:109-1022.</mixed-citation></ref><ref id="B30"><mixed-citation>30.&amp;nbsp;&amp;nbsp;&amp;nbsp; Umreda M. et al. Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability // J. Biol. Chem. 2009. Vol. 284, N 33: 22166&amp;ndash;22172.</mixed-citation></ref><ref id="B31"><mixed-citation>31.&amp;nbsp;&amp;nbsp;&amp;nbsp; Weydig C. et al. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity // Exp. Cell. Res.&amp;nbsp; 2007.&amp;nbsp; Vol. 313, N 16: 3459-3471.</mixed-citation></ref><ref id="B32"><mixed-citation>&amp;nbsp;</mixed-citation></ref></ref-list></back></article>